Machado-Joseph disease/spinocerebellar ataxia type 3
- PMID: 21827905
- PMCID: PMC3568768
- DOI: 10.1016/B978-0-444-51892-7.00027-9
Machado-Joseph disease/spinocerebellar ataxia type 3
Abstract
Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), may be the most common dominantly inherited ataxia in the world. Here I will review historical, clinical, neuropathological, genetic, and pathogenic features of MJD, and finish with a brief discussion of present, and possible future, treatment for this currently incurable disorder. Like many other dominantly inherited ataxias, MJD/SCA3 shows remarkable clinical heterogeneity, reflecting the underlying genetic defect: an unstable CAG trinucleotide repeat that varies in size among affected persons. This pathogenic repeat in MJD/SCA3 encodes an expanded tract of the amino acid glutamine in the disease protein, which is known as ataxin-3. MJD/SCA3 is one of nine identified polyglutamine neurodegenerative diseases which share features of pathogenesis centered on protein misfolding and accumulation. The specific properties of MJD/SCA3 and its disease protein are discussed in light of what is known about the entire class of polyglutamine diseases.
2012 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.Arch Neurol. 2000 Apr;57(4):540-4. doi: 10.1001/archneur.57.4.540. Arch Neurol. 2000. PMID: 10768629
-
A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.Neurobiol Dis. 2015 Jan;73:174-88. doi: 10.1016/j.nbd.2014.09.020. Epub 2014 Oct 7. Neurobiol Dis. 2015. PMID: 25301414
-
[Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Dec;25(6):660-2. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008. PMID: 19065526 Review. Chinese.
-
Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report.BMC Neurol. 2011 Oct 24;11:131. doi: 10.1186/1471-2377-11-131. BMC Neurol. 2011. PMID: 22023810 Free PMC article.
-
Toward understanding Machado-Joseph disease.Prog Neurobiol. 2012 May;97(2):239-57. doi: 10.1016/j.pneurobio.2011.11.006. Epub 2011 Nov 23. Prog Neurobiol. 2012. PMID: 22133674 Free PMC article. Review.
Cited by
-
Cell-Free and In Vivo Characterization of the Inhibitory Activity of Lavado Cocoa Flavanols on the Amyloid Protein Ataxin-3: Toward New Approaches against Spinocerebellar Ataxia Type 3.ACS Chem Neurosci. 2024 Jan 17;15(2):278-289. doi: 10.1021/acschemneuro.3c00560. Epub 2023 Dec 28. ACS Chem Neurosci. 2024. PMID: 38154144 Free PMC article.
-
A Case of Orthognathic Surgery for Jaw Deformity in a Patient with Spinocerebellar Ataxia.Plast Reconstr Surg Glob Open. 2022 Apr 13;10(4):e4257. doi: 10.1097/GOX.0000000000004257. eCollection 2022 Apr. Plast Reconstr Surg Glob Open. 2022. PMID: 35433154 Free PMC article.
-
The challenge of producing ubiquitinated proteins for structural studies.Cells. 2014 Jun 12;3(2):639-56. doi: 10.3390/cells3020639. Cells. 2014. PMID: 24926903 Free PMC article.
-
Promoter Variant Alters Expression of the Autophagic BECN1 Gene: Implications for Clinical Manifestations of Machado-Joseph Disease.Cerebellum. 2017 Dec;16(5-6):957-963. doi: 10.1007/s12311-017-0875-4. Cerebellum. 2017. PMID: 28699106
-
The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models.Front Mol Neurosci. 2017 Jun 20;10:196. doi: 10.3389/fnmol.2017.00196. eCollection 2017. Front Mol Neurosci. 2017. PMID: 28676741 Free PMC article.
References
-
- Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntington and the risk of neuronal death. Nature. 2004;431:805–810. - PubMed
-
- Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001;292:1552–5. - PubMed
-
- Berke SJ, Chai Y, Marrs GL, Wen H, Paulson HL. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J Biol Chem. 2005;280(36):32026–34. Epub 2005 Jul 21. - PubMed
-
- Berke SJ, Schmied FA, Brunt ER, Ellerby LM, Paulson HL. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3. J. Neurochem. 2004 May;89(4):908–18. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources